Cannabinoid Pathway Expression

Cannabinoid pathway expression refers to the genetic and biochemical mechanisms that regulate how cannabis plants synthesize and accumulate cannabinoids like THC and CBD. This trait is controlled by multiple genes, including CBDA synthase and THCA synthase, which determine whether a plant expresses primarily acidic precursors (CBDA, THCA) or post-decarboxylation cannabinoids. Breeders classify strains by their cannabinoid expression profiles—chemotype I (THC-dominant), chemotype II (balanced THC/CBD), and chemotype III (CBD-dominant)—based on enzymatic activity and genetic inheritance. Environmental factors, plant maturity, and temperature also influence the final cannabinoid ratio, making pathway expression a complex trait that involves both fixed genetics and phenotypic plasticity. Understanding these pathways is essential for targeted breeding programs seeking consistent cannabinoid o

Breeders select for specific pathway expression patterns by backcrossing to parents with known chemotypes and monitoring CBDA/THCA ratios in early plant development. Molecular markers linked to synthase genes are increasingly used in breeding programs to predict cannabinoid expression before flowering, accelerating cultivar development.